Ammonium formate → (S)-1-[2-(4-hydroxyphenyl)ethyl]-2-methyl-7-(8-oxa-3-azabicyclo[3.2.1]oct-3-yl)-2-trifluoromethyl-2,3-dihydro-1H-imidazo[1,2-a]pyrimidin-5-one
Reaction equation
C([O-])=O.[NH4+].C([O:12][C:13]1[CH:18]=[CH:17][C:16]([CH2:19][CH2:20][N:21]2[C:25]3=[N:26][C:27]([N:31]4[CH2:37][CH:36]5[O:38][CH:33]([CH2:34][CH2:35]5)[CH2:32]4)=[CH:28][C:29](=[O:30])[N:24]3[CH2:23][C@@:22]2([CH3:43])[C:39]([F:42])([F:41])[F:40])=[CH:15][CH:14]=1)C1C=CC=CC=1>CO.[OH-].[Pd+2].[OH-]>[OH:12][C:13]1[CH:18]=[CH:17][C:16]([CH2:19][CH2:20][N:21]2[C:25]3=[N:26][C:27]([N:31]4[CH2:32][CH:33]5[O:38][CH:36]([CH2:35][CH2:34]5)[CH2:37]4)=[CH:28][C:29](=[O:30])[N:24]3[CH2:23][C@@:22]2([CH3:43])[C:39]([F:42])([F:41])[F:40])=[CH:15][CH:14]=1Participants
Reactant 2
Product 1
Reagents, catalysts & solvents 2
Procedure
700 mg (11.10 mmol) of ammonium formate and 156 mg (0.22 mmol) of 20% palladium hydroxide are added at 0° C. to a solution of 1.20 g (2.22 mmol) of (S)-1-[2-(4-benzyloxyphenyl)ethyl]-2-methyl-7-(8-oxa-3-azabicyclo[3.2.1]oct-3-yl)-2-trifluoromethyl-2,3-dihydro-1H-imidazo[1,2-a]pyrimidin-5-one in 15 mL of methanol. The mixture is refluxed for 1 hour and then allowed to cool to room temperature. The reaction medium is filtered through Celite and the filtrate is then evaporated to dryness. After purification by chromatography on silica gel (eluent A/B: DCM/MeOH, gradient A/B: t 0 min 0% B, t 25 min 10% B, t 30 min 10% B), 732 mg of (S)-1-[2-(4-hydroxyphenyl)ethyl]-2-methyl-7-(8-oxa-3-azabicyclo[3.2.1]oct-3-yl)-2-trifluoromethyl-2,3-dihydro-1H-imidazo[1,2-a]pyrimidin-5-one were obtained, corresponding to the following characteristics:
Workup
- temperatureThe mixture is refluxed for 1 hour
- filtrationThe reaction medium is filtered through Celite
- customthe filtrate is then evaporated to dryness
- customAfter purification by chromatography on silica gel (eluent A/B: DCM/MeOH, gradient A/B: t 0 min 0% B, t 25 min 10% B, t 30 min 10% B), 732 mg of (S)-1-[2-(4-hydroxyphenyl)ethyl]-2-methyl-7-(8-oxa-3-azabicyclo[3.2.1]oct-3-yl)-2-trifluoromethyl-2,3-dihydro-1H-imidazo[1,2-a]pyrimidin-5-one
- customwere obtained, corresponding to the following characteristics
Sources & evidence
- ORD record
- ord-c245a8dcb4434ed4967f845a31b1c463
- Source dataset
- uspto-grants-2016_04
- Patent number
- US09321790B2
Reaction notes
Loading…